Development of Radiotracers for Imaging of the PD-1/PD-L1 Axis

Immune checkpoint inhibitor (ICI) therapy has emerged as a major treatment option for a variety of cancers. Among the immune checkpoints addressed, the programmed death receptor 1 (PD-1) and its ligand PD-L1 are the key targets for an ICI. PD-L1 has especially been proven to be a reproducible biomar...

Descripción completa

Detalles Bibliográficos
Autores principales: Krutzek, Fabian, Kopka, Klaus, Stadlbauer, Sven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228425/
https://www.ncbi.nlm.nih.gov/pubmed/35745666
http://dx.doi.org/10.3390/ph15060747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228425/
https://www.ncbi.nlm.nih.gov/pubmed/35745666
http://dx.doi.org/10.3390/ph15060747

Ejemplares similares